Sometimes when I sit to write these blogs I feel as though I
may be preaching to the choir. After
all, Abby emails these to clinics who send urine samples to the lab to be
tested, so they most likely know the information I am attempting to deliver,
right? Not so much! The questions we receive on a daily basis
reinforce the necessity of the partnership the lab has with the clinics it
serves. Our job is to deliver accurate
information to the providers in order for them to make the best possible
clinical decision for their patient. We
take this seriously and writing this biweekly blog is a way to help insure we
are assisting in the provider/patient relationship to the best of our
ability. If there is a subject matter
involving drug testing you would like to have discussed please let us know and
we will make every effort to include that in a blog.
A toxicology report can be an intimidating bit of
information to those unfamiliar with it.
Many providers are unfamiliar with the complexities of UDT and therefore
fail to use it. One study I recently
read found that only 8% of family physicians performed UDT for patients they
had on some form of chronic opioid therapy.
The reasons given for the absence of testing were: the providers did not
know which patients to test, how often to test them and what the results of the
testing meant. Experience has taught me
this is not limited to primary care physicians.
Although it is not the lab’s job, nor are we allowed to practice
medicine, I do think it is our responsibility to help educate providers on drug
testing. This does not mean mark a
requisition form telling them to test everything, but instead our
responsibility is to deliver all of the objective and accurate information
necessary enabling the provider to make the most appropriate medical decision
for their patient.
Sadly, in many offices, urinary drug testing has become an
inexpensive insurance policy for provider liability protection. Instead of using UDT as intended, many
providers simply use UDT as a means to discharge patients from their
practice. Clinically the benefits of UDT
include reducing the risk for toxicity from adverse drug effects, detecting
patient non-compliance, reducing risk of therapeutic failure and avoiding or
detecting drug-drug interaction. As your
toxicology lab we are here to assist you in taking advantage of those
benefits. Although on occasion it
becomes necessary, discharging patients helps no one. Please take advantage of the lab personnel
cell phone list and let us help with your questions.
As always, we appreciate your business and thank you for
it. I leave you with a quote from
Aristotle: “We are what we repeatedly do.
Excellence then, is not an act, it is a habit”.
Lance Benedict
President/CEO
Industry Lab Diagnostic Partners
7/26/2019
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.